GenMark Diagnostics Reaffirms FY2019 Sales Guidance of $85M-90M vs $87.86M

GenMark Diagnostics (NASDAQ:GNMK) . raises FY2019 sales outlook from $85 million-90 million to $85 million-90 million.

Benzinga · 11/06/2019 22:03

GenMark Diagnostics (NASDAQ:GNMK) . raises FY2019 sales outlook from $85 million-90 million to $85 million-90 million.